• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺铁会影响射血分数保留的心力衰竭患者的预后,但对运动能力的影响较小。

Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction.

作者信息

Barandiarán Aizpurua Arantxa, Sanders-van Wijk Sandra, Brunner-La Rocca Hans-Peter, Henkens Michiel T H M, Weerts Jerremy, Spanjers Mireille H A, Knackstedt Christian, van Empel Vanessa P M

机构信息

Department of Cardiology, Maastricht University Medical Centre (MUMC+), PO 5800, Maastricht, 6202AZ, The Netherlands.

Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.

出版信息

ESC Heart Fail. 2021 Apr;8(2):1304-1313. doi: 10.1002/ehf2.13204. Epub 2021 Jan 31.

DOI:10.1002/ehf2.13204
PMID:33522131
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8006701/
Abstract

AIMS

Whether and how iron deficiency (ID) impacts patients with heart failure (HF) with preserved ejection fraction (HFpEF) remain unclear. The aim of our study was to investigate the impact of ID on functional status, exercise capacity, and prognosis in HFpEF.

METHODS AND RESULTS

The study population consisted of 300 HFpEF patients. ID was defined as serum ferritin <100 μg/L or 100-300 μg/L and transferrin-saturation <20%. Baseline functional status, quality of life (HADS score and EQ 5D index), 6 min walking test, echocardiography, and outcome (all-cause mortality and combined all cause-mortality and HF hospitalization) were evaluated. ID was found in 159 (53%) patients. Patients with ID had a worse prognosis with a higher combined endpoint of all-cause mortality and HF hospitalization after 4 years of follow-up (log rank = 0.008). Pulmonary hypertension, depression, and thyroid disease were more prevalent in the ID group. Multivariable analysis showed that ID was independently associated with body mass index (P = 0.003), pulmonary hypertension (P = 0.008), and thyroid disease (P = 0.01). Although patients with ID had a lower exercise capacity compared with patients without ID (393 m [294-455] vs. 344 m [260-441], P = 0.008), there was no significant correlation after multivariable correction for age, BMI, NT-proBNP, DM, and depression.

CONCLUSIONS

Heart failure with preserved ejection fraction patients with ID have a worse prognosis and impaired exercise capacity compared with those without ID. However, although a trend was observed, after multivariable correction ID was no longer significantly associated with a reduced exercise capacity. This reflects that impaired exercise capacity in HFpEF is complex and seems multifactorial. Interestingly, pulmonary hypertension was an independent predictor of both ID and exercise capacity.

摘要

目的

缺铁(ID)是否以及如何影响射血分数保留的心力衰竭(HFpEF)患者仍不清楚。我们研究的目的是调查ID对HFpEF患者功能状态、运动能力和预后的影响。

方法和结果

研究人群包括300例HFpEF患者。ID定义为血清铁蛋白<100μg/L或100 - 300μg/L且转铁蛋白饱和度<20%。评估了基线功能状态、生活质量(医院焦虑抑郁量表评分和EQ 5D指数)、6分钟步行试验、超声心动图以及结局(全因死亡率和全因死亡率与HF住院率的综合指标)。159例(53%)患者存在ID。ID患者预后较差,随访4年后全因死亡率和HF住院率的综合终点更高(对数秩检验=0.008)。ID组中肺动脉高压、抑郁症和甲状腺疾病更为常见。多变量分析显示,ID与体重指数独立相关(P = 0.003)、肺动脉高压(P = 0.008)和甲状腺疾病(P = 0.01)。尽管与无ID的患者相比,ID患者的运动能力较低(393米[294 - 455] vs. 344米[260 - 441],P = 0.008),但在对年龄、体重指数、N末端脑钠肽前体、糖尿病和抑郁症进行多变量校正后,无显著相关性。

结论

与无ID的射血分数保留的心力衰竭患者相比,有ID的患者预后更差且运动能力受损。然而,尽管观察到一种趋势,但在多变量校正后,ID与运动能力降低不再显著相关。这反映出HFpEF中运动能力受损是复杂的,似乎是多因素的。有趣的是,肺动脉高压是ID和运动能力的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3796/8006701/703f92c58182/EHF2-8-1304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3796/8006701/1210478611b7/EHF2-8-1304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3796/8006701/d2c55e0acb29/EHF2-8-1304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3796/8006701/703f92c58182/EHF2-8-1304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3796/8006701/1210478611b7/EHF2-8-1304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3796/8006701/d2c55e0acb29/EHF2-8-1304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3796/8006701/703f92c58182/EHF2-8-1304-g002.jpg

相似文献

1
Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction.缺铁会影响射血分数保留的心力衰竭患者的预后,但对运动能力的影响较小。
ESC Heart Fail. 2021 Apr;8(2):1304-1313. doi: 10.1002/ehf2.13204. Epub 2021 Jan 31.
2
Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.射血分数保留的心力衰竭患者的铁缺乏及其与运动能力降低、肌肉力量和生活质量下降的关系。
Clin Res Cardiol. 2019 Feb;108(2):203-211. doi: 10.1007/s00392-018-1344-x. Epub 2018 Jul 26.
3
Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction.缺铁对射血分数降低、中等范围及保留的心力衰竭患者运动能力和预后的影响。
Acta Cardiol. 2018 Apr;73(2):115-123. doi: 10.1080/00015385.2017.1351239. Epub 2017 Jul 21.
4
Iron deficiency in new onset heart failure: association with clinical factors and quality of life.缺铁性心力衰竭:与临床因素和生活质量的关系。
ESC Heart Fail. 2024 Oct;11(5):2661-2671. doi: 10.1002/ehf2.14849. Epub 2024 May 27.
5
[Impact of iron deficiency on prognosis of heart failure patients with preserved ejection fraction].缺铁对射血分数保留的心力衰竭患者预后的影响
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 May 24;49(5):479-486. doi: 10.3760/cma.j.cn112148-20210104-00018.
6
Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中的功能性缺铁与舒张功能
Int J Cardiol. 2013 Oct 12;168(5):4652-7. doi: 10.1016/j.ijcard.2013.07.185. Epub 2013 Jul 30.
7
Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction.缺铁:对射血分数保留的心力衰竭患者功能能力和生活质量的影响
J Clin Med. 2020 Apr 22;9(4):1199. doi: 10.3390/jcm9041199.
8
Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype.根据射血分数表型,铁状态随时间变化对心力衰竭临床结局的影响。
ESC Heart Fail. 2021 Dec;8(6):4572-4583. doi: 10.1002/ehf2.13617. Epub 2021 Sep 30.
9
Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study.缺铁对射血分数保留的心力衰竭患者的舒张功能、有氧运动能力及患者表型分析的影响:OptimEx-Clin研究的亚组分析
Front Physiol. 2022 Feb 10;12:757268. doi: 10.3389/fphys.2021.757268. eCollection 2021.
10
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial.铁羧基麦芽糖与射血分数保留的心力衰竭伴铁缺乏患者的运动能力:FAIR-HFpEF 试验。
Eur Heart J. 2024 Oct 5;45(37):3789-3800. doi: 10.1093/eurheartj/ehae479.

引用本文的文献

1
Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study.射血分数保留的心力衰竭患者多器官微血管功能障碍:PROSE-HFpEF病例对照研究
Cardiovasc Diabetol. 2025 Jul 30;24(1):310. doi: 10.1186/s12933-025-02850-1.
2
Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者中糖尿病和蛋白尿的时间患病率及预后影响
Cardiovasc Diabetol. 2025 Apr 5;24(1):156. doi: 10.1186/s12933-025-02708-6.
3
Prevalence and Adverse Outcomes of Iron Deficiency in Heart Failure.

本文引用的文献

1
Erratum: Reference Equations for the Six-Minute Walk in Healthy Adults.勘误:健康成年人六分钟步行试验的参考方程。
Am J Respir Crit Care Med. 2020 Feb 1;201(3):393. doi: 10.1164/rccm.v201erratum1.
2
Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF Studies.心力衰竭患者低铁储存与铁利用障碍的临床特征和结局差异:来自 DEFINE-HF 和 BIOSTAT-CHF 研究的结果。
JAMA Cardiol. 2019 Jul 1;4(7):696-701. doi: 10.1001/jamacardio.2019.1739.
3
Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
心力衰竭中铁缺乏的患病率及不良后果
Curr Cardiol Rev. 2025;21(5):104-111. doi: 10.2174/011573403X351268250130070459.
4
Retinal Vascular Changes in Heart Failure with Preserved Ejection Fraction Using .射血分数保留的心力衰竭患者的视网膜血管变化 采用…… (原文此处不完整)
J Clin Med. 2024 Mar 25;13(7):1892. doi: 10.3390/jcm13071892.
5
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.射血分数保留的心力衰竭:诊断、风险评估和治疗。
Clin Res Cardiol. 2024 Sep;113(9):1287-1305. doi: 10.1007/s00392-024-02396-4. Epub 2024 Apr 11.
6
Anemia and Iron Deficiency Predict All-Cause Mortality in Patients with Heart Failure and Preserved Ejection Fraction: 6-Year Follow-Up Study.贫血和缺铁预示射血分数保留的心力衰竭患者的全因死亡率:6年随访研究
Diagnostics (Basel). 2024 Jan 18;14(2):209. doi: 10.3390/diagnostics14020209.
7
Relationship between serum iron level and physical function in heart failure patients is lost by presence of diabetes.糖尿病存在时,心力衰竭患者的血清铁水平与身体功能之间的关系丧失。
ESC Heart Fail. 2024 Feb;11(1):513-523. doi: 10.1002/ehf2.14610. Epub 2023 Dec 13.
8
Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.射血分数保留的心力衰竭的药物治疗和合并症管理进展:来自临床试验的证据
Heart Fail Rev. 2024 Mar;29(2):305-320. doi: 10.1007/s10741-023-10338-x. Epub 2023 Aug 10.
9
A year in heart failure: updates of clinical and preclinical findings.心力衰竭的一年:临床和临床前研究进展。
ESC Heart Fail. 2023 Aug;10(4):2150-2158. doi: 10.1002/ehf2.14377. Epub 2023 Apr 18.
10
Advances in extracardiac mechanisms for heart failure with preserved ejection fraction.射血分数保留心力衰竭的心脏外机制研究进展。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Dec 28;47(12):1733-1739. doi: 10.11817/j.issn.1672-7347.2022.220310.
射血分数保留的心力衰竭中的缺铁:一项系统评价和荟萃分析。
Open Heart. 2019 Apr 3;6(1):e001012. doi: 10.1136/openhrt-2019-001012. eCollection 2019.
4
Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.射血分数保留的心力衰竭患者的铁缺乏及其与运动能力降低、肌肉力量和生活质量下降的关系。
Clin Res Cardiol. 2019 Feb;108(2):203-211. doi: 10.1007/s00392-018-1344-x. Epub 2018 Jul 26.
5
Iron deficiency is associated with Hypothyroxinemia and Hypotriiodothyroninemia in the Spanish general adult population: Di@bet.es study.缺铁与西班牙一般成年人群中的甲状腺素血症和三碘甲状腺原氨酸血症有关:Di@bet.es 研究。
Sci Rep. 2018 Apr 26;8(1):6571. doi: 10.1038/s41598-018-24352-9.
6
Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction.缺铁对射血分数降低、中等范围及保留的心力衰竭患者运动能力和预后的影响。
Acta Cardiol. 2018 Apr;73(2):115-123. doi: 10.1080/00015385.2017.1351239. Epub 2017 Jul 21.
7
Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners.心力衰竭合并缺铁患者的铁剂治疗:面向从业者的铁剂制剂综述
Am J Cardiovasc Drugs. 2017 Jun;17(3):183-201. doi: 10.1007/s40256-016-0211-2.
8
Prevalence of thyroid autoimmunity and dysfunction in women with iron deficiency during early pregnancy: is it altered?孕早期缺铁女性甲状腺自身免疫及功能障碍的患病率:是否发生了改变?
Eur J Endocrinol. 2016 Sep;175(3):191-9. doi: 10.1530/EJE-16-0288. Epub 2016 Jul 22.
9
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会(HFA)特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
10
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.